FRED B CRAVES Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FRED B CRAVES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FRED B CRAVES. FRED B CRAVES is Director in SYNTA PHARMACEUTICALS CORP ($SNTA) and in Dermira, Inc. ($DERM) and Director in Dermira, Inc. ($DERM) and Director in Twist Bioscience Corp ($TWST).
Latest Insider Trading Transactions of FRED B CRAVES
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DERM, SNTA, TWST
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 04 2020 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Sell | J | 0.00 | 45,460 | 0 | 43,537 | 89 K to 43.5 K (-51.08 %) |
| Sep 04 2020 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Sell | J | 0.00 | 45,460 | 0 | 43,537 | 89 K to 43.5 K (-51.08 %) |
| Sep 04 2020 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Sell | J | 0.00 | 31,650 | 0 | 49,730 | 81.4 K to 49.7 K (-38.89 %) |
| Sep 04 2020 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Sell | J | 0.00 | 31,650 | 0 | 49,730 | 81.4 K to 49.7 K (-38.89 %) |
| Sep 04 2020 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Sell | J | 0.00 | 1,468,350 | 0 | 2,260,791 | 3.7 M to 2.3 M (-39.38 %) |
| Sep 04 2020 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Sell | J | 0.00 | 1,468,350 | 0 | 2,260,791 | 3.7 M to 2.3 M (-39.38 %) |
| Aug 19 2020 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Sell | S | 107.64 | 7,303 | 786,095 | 42,875 | 50.2 K to 42.9 K (-14.55 %) |
| Aug 19 2020 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Sell | S | 110.03 | 10,197 | 1,121,976 | 50,178 | 60.4 K to 50.2 K (-16.89 %) |
| Aug 19 2020 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Sell | S | 110.73 | 12,500 | 1,384,125 | 60,375 | 72.9 K to 60.4 K (-17.15 %) |
| Jun 18 2020 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Option Exercise | A | 111.06 | 6,000 | 666,360 | 6,000 | |
| May 29 2020 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Sell | J | 0.00 | 44,903 | 0 | 72,875 | 117.8 K to 72.9 K (-38.13 %) |
| May 29 2020 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Sell | J | 0.00 | 44,903 | 0 | 72,875 | 117.8 K to 72.9 K (-38.13 %) |
| May 29 2020 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Sell | J | 0.00 | 6,772 | 0 | 81,380 | 88.2 K to 81.4 K (-7.68 %) |
| May 29 2020 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Sell | J | 0.00 | 6,772 | 0 | 81,380 | 88.2 K to 81.4 K (-7.68 %) |
| May 29 2020 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Sell | J | 0.00 | 360,561 | 0 | 3,729,141 | 4.1 M to 3.7 M (-8.82 %) |
| May 29 2020 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Sell | J | 0.00 | 360,561 | 0 | 3,729,141 | 4.1 M to 3.7 M (-8.82 %) |
| Feb 24 2020 | DERM | Dermira, Inc. | CRAVES FRED B | Option Exercise | D | 0.00 | 3,000 | 0 | 0 | ||
| Feb 24 2020 | DERM | Dermira, Inc. | CRAVES FRED B | Option Exercise | D | 9.38 | 6,000 | 56,280 | 0 | ||
| Feb 24 2020 | DERM | Dermira, Inc. | CRAVES FRED B | Option Exercise | D | 9.95 | 6,000 | 59,700 | 0 | ||
| Feb 24 2020 | DERM | Dermira, Inc. | CRAVES FRED B | Option Exercise | D | 28.01 | 6,000 | 168,060 | 0 | ||
| Feb 24 2020 | DERM | Dermira, Inc. | CRAVES FRED B | Option Exercise | D | 28.82 | 10,344 | 298,114 | 0 | ||
| Feb 24 2020 | DERM | Dermira, Inc. | CRAVES FRED B | Option Exercise | D | 16.00 | 10,334 | 165,344 | 0 | ||
| Feb 24 2020 | DERM | Dermira, Inc. | CRAVES FRED B | Sell | D | 18.75 | 30,000 | 562,500 | 0 | 30 K to 0 (-100.00 %) | |
| Feb 24 2020 | DERM | Dermira, Inc. | CRAVES FRED B | Sell | D | 18.75 | 65,572 | 1,229,475 | 0 | 65.6 K to 0 (-100.00 %) | |
| Feb 24 2020 | DERM | Dermira, Inc. | CRAVES FRED B | Sell | D | 18.75 | 3,441,075 | 64,520,156 | 0 | 3.4 M to 0 (-100.00 %) | |
| Feb 24 2020 | DERM | Dermira, Inc. | CRAVES FRED B | Sell | D | 18.75 | 6,000 | 112,500 | 0 | 6 K to 0 (-100.00 %) | |
| Dec 13 2019 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Sell | S | 105.47 | 25,320 | 2,670,500 | 88,152 | 113.5 K to 88.2 K (-22.31 %) |
| Dec 13 2019 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Sell | S | 105.47 | 1,174,680 | 123,893,500 | 4,089,702 | 5.3 M to 4.1 M (-22.31 %) |
| Oct 09 2019 | TWST | Twist Bioscience C ... | CRAVES FRED B | Director | Option Exercise | A | 30.41 | 5,590 | 169,992 | 5,590 | |
| Jul 01 2019 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Option Exercise | A | 100.45 | 10,000 | 1,004,500 | 10,000 | |
| Jun 14 2019 | DERM | Dermira, Inc. | CRAVES FRED B | Option Exercise | M | 0.00 | 3,000 | 0 | 0 | ||
| Jun 14 2019 | DERM | Dermira, Inc. | CRAVES FRED B | Buy | M | 0.00 | 3,000 | 0 | 6,000 | 3 K to 6 K (+100.00 %) | |
| Jun 06 2019 | DERM | Dermira, Inc. | CRAVES FRED B | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | ||
| Jun 06 2019 | DERM | Dermira, Inc. | CRAVES FRED B | Option Exercise | A | 9.38 | 6,000 | 56,280 | 6,000 | ||
| Nov 19 2018 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Buy | P | 125.00 | 900 | 112,500 | 298,067 | 297.2 K to 298.1 K (+0.30 %) |
| Nov 19 2018 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Buy | P | 124.57 | 1,000 | 124,570 | 297,167 | 296.2 K to 297.2 K (+0.34 %) |
| Nov 19 2018 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Buy | P | 123.17 | 100 | 12,317 | 296,167 | 296.1 K to 296.2 K (+0.03 %) |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRAVES FRED B | Director | Option Exercise | C | 0.00 | 8,603 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRAVES FRED B | Director | Option Exercise | C | 0.00 | 7,158 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRAVES FRED B | Director | Option Exercise | C | 0.00 | 51,010 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRAVES FRED B | Director | Buy | C | 0.00 | 8,603 | 0 | 66,771 | 58.2 K to 66.8 K (+14.79 %) |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRAVES FRED B | Director | Buy | C | 0.00 | 7,158 | 0 | 58,168 | 51 K to 58.2 K (+14.03 %) |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRAVES FRED B | Director | Buy | C | 0.00 | 51,010 | 0 | 51,010 | 0 to 51 K |
| Jun 21 2018 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Option Exercise | A | 303.79 | 10,000 | 3,037,900 | 10,000 | |
| Jun 14 2018 | DERM | Dermira, Inc. | CRAVES FRED B | Option Exercise | M | 0.00 | 3,000 | 0 | 0 | ||
| Jun 14 2018 | DERM | Dermira, Inc. | CRAVES FRED B | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | ||
| Jun 14 2018 | DERM | Dermira, Inc. | CRAVES FRED B | Option Exercise | A | 9.95 | 6,000 | 59,700 | 6,000 | ||
| Jun 14 2018 | DERM | Dermira, Inc. | CRAVES FRED B | Buy | M | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K | |
| Jun 12 2018 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Buy | S | 287.46 | 5,908 | 1,698,314 | 113,472 | 107.6 K to 113.5 K (+5.49 %) |
| Jun 12 2018 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Buy | S | 287.46 | 5,908 | 1,698,314 | 113,472 | 107.6 K to 113.5 K (+5.49 %) |
| Jun 12 2018 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Sell | S | 287.46 | 274,092 | 78,790,486 | 5,264,382 | 5.5 M to 5.3 M (-4.95 %) |
| Jun 12 2018 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Sell | S | 287.46 | 274,092 | 78,790,486 | 5,264,382 | 5.5 M to 5.3 M (-4.95 %) |
| Aug 14 2017 | DERM | Dermira, Inc. | CRAVES FRED B | Buy | P | 23.95 | 10,000 | 239,460 | 30,000 | 20 K to 30 K (+50.00 %) | |
| Aug 14 2017 | DERM | Dermira, Inc. | CRAVES FRED B | Buy | P | 22.57 | 20,000 | 451,470 | 20,000 | 0 to 20 K | |
| Jun 30 2017 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Option Exercise | A | 16.46 | 10,000 | 164,600 | 10,000 | |
| Jun 15 2017 | DERM | Dermira, Inc. | CRAVES FRED B | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | ||
| Jun 15 2017 | DERM | Dermira, Inc. | CRAVES FRED B | Option Exercise | A | 28.01 | 6,000 | 168,060 | 6,000 | ||
| Oct 24 2016 | SNTA | MADRIGAL PHARMACEU ... | CRAVES FRED B | Director | Option Exercise | A | 12.01 | 20,000 | 240,200 | 20,000 | |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | CRAVES FRED B | Director | Grant | A | 0.00 | 119,380 | 0 | 119,380 | 0 to 119.4 K |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | CRAVES FRED B | Director | Grant | A | 0.00 | 5,538,474 | 0 | 5,538,474 | 0 to 5.5 M |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | CRAVES FRED B | Director | Grant | A | 0.00 | 296,067 | 0 | 296,067 | 0 to 296.1 K |
| Jun 23 2016 | DERM | Dermira, Inc. | CRAVES FRED B | Option Exercise | A | 28.82 | 10,344 | 298,114 | 10,344 | ||
| Jun 15 2015 | DERM | Dermira, Inc. | CRAVES FRED B | Director | Option Exercise | A | 16.00 | 10,344 | 165,504 | 10,344 |
Page: 1